Calumet posts FY 2025 net loss of USD 33.8 million

Reuters
02/27
Calumet posts FY 2025 net loss of USD 33.8 million

Calumet reported Q4 FY2025 sales of USD 1.0 billion and a net loss of USD 37.3 million (USD 0.43 basic loss per share). Q4 adjusted EBITDA was USD 48.4 million and adjusted EBITDA with tax attributes was USD 69.3 million. For FY2025, Calumet posted sales of USD 4.1 billion and a net loss of USD 33.8 million (USD 0.39 basic loss per share). FY adjusted EBITDA was USD 211.2 million, while adjusted EBITDA with tax attributes was USD 293.3 million. The company said it reduced recourse debt by USD 222 million in 2025 and generated strong free cash flow driven by approximately USD 100 million of cost reduction initiatives. By segment in Q4, Specialty Products and Solutions adjusted EBITDA was USD 88.5 million, Performance Brands adjusted EBITDA was USD 5.4 million, and Montana/Renewables adjusted EBITDA with tax attributes was a loss of USD 5.4 million. Calumet said Montana Renewables’ MaxSAF 150 expansion remains on track for Q2 2026. The company also noted proposed U.S. Treasury/IRS regulations under Section 45Z and said an additional USD 8.4 million in 2025 clean fuel production credits were generated based on estimate updates made in Q1 2026. In January 2026, Calumet closed a USD 405 million private placement of 9.75% senior notes due 2031 and used the proceeds, along with cash and revolver borrowings, to redeem its 11.00% senior notes due 2026 and 8.125% senior notes due 2027. Calumet also amended its asset-based loan facility to extend maturity to January 2031, with total commitments of USD 500 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calumet Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602270700PR_NEWS_USPR_____DE97482) on February 27, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10